




FORMULATION AND EVALUATION OF RACECADOTRIL MUCOADHESIVE MICROSPHERES 
 
KANCHAN JAMKAR1, SWATI MUTHA1, SHARVAREE HARDIKAR2, NIKHIL KUMBHAR1 
1Department of Pharmaceutics, SGRS College of Pharmacy, Saswad Pune, 2Department of Pharmaceutics, Allana College of Pharmacy, 
Pune 
Email: swati.mutha@rediffmail.com 
Received: 16 Oct 2019, Revised and Accepted: 20 Dec 2019 
ABSTRACT 
Objective: To develop and evaluate the mucoadhesive microsphere using combinations of natural polymers chitosan and xanthan gum for 
sustained release. 
Methods: In the present work mucoadhesive microspheres were prepared by using natural polymers like chitosan and xanthan gum by using the 
emulsion chemical cross-linking method. Chemical cross-linking was done by using glutaraldehyde. The 22 factorial design was employed to show 
the effect of cross-linking agent and processing factor-like stirring and speed. Prepared microspheres were evaluated for their particle size, surface 
morphology, drug entrapment efficiency, in vitro drug release, swelling index, and mucoadhesive strength. 
Results: The size of microspheres of factorial batches were in the range of 26-46 µm. The swelling index was showed in the range of 1.51-1.66 
percentage. The equation of multiple regression revealed that there was significant interaction among factors. The glutaraldehyde concentration 
had a positive effect on % entrapment efficiency, % cumulative drug release and % mucoadhesion. Stirring speed showed a negative impact on % 
entrapment efficiency, % cumulative drug release and % mucoadhesion. The interactive effect of glutaraldehyde concentration and the stirring 
speed was found to be positive for % entrapment efficiency and % cumulative drug release. In vitro drug release study of optimized formulation F2 
show 96 % of drug release with 6 h indicating sustained release behavior with diffusion mechanism. The SEM image of the optimized batch was 
spherical with a porous surface. 
Conclusion: The results obtained in this research work indicated that a promising potential of chitosan and xanthan gum combination for the 
preparation of the mucoadhesive microsphere of Racecadotril. 
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INTRODUCTION 
The concept of multiple unit dosage forms was initially introduced in 
the early nineteen-fifties. Multiparticulate subunit, typically 
consisting of thousands of spherical with 0.005-2.00 mm. Recent 
trends showed that the multiparticulate drug delivery system is 
suitable for achieving the controlled release or prolong release 
formulations with no risks of dose dumping. Thus multiparticulate 
drug delivery system provides incredible opportunities for 
designing controlled release formulations [1-2]. 
Mucoadhesion is the topic of current interest in the design of the 
drug delivery system to prolong the residence time of the dosage 
form. Mucoadhesive Microsphere has advantageous like efficient 
absorption and enhanced bioavailability of the drug due to the high 
surface of volume ratio, much more contact with the mucous layer 
[3-5]. The mucoadhesive system adheres to the mucus. This 
adhesion is a result of electrostatic and H-bond formation at the 
mucus-polymer boundary. The bond formation is prevented by the 
acidic environment and thick mucus present in the stomach, to 
overcome this problem cationic polymer chitosan is used which is 
known to bind well to GI track mucus and act as a penetration 
enhancer. Racecadotril is a thiorphan metabolite derivative, an 
enkephalinase inhibitor, which has antisecretory activity [6, 7]. It is 
active on v-cholera bacteria in the gut by inhibiting adenylate 
cyclase. Racecadotril is approved for secretory diarrhea. It is also 
good for bacterial diarrhea and gonorrhea. Racecadotril is rapidly 
absorbed from the gastrointestinal tract. This drug has a repetitive 
dose schedule (100 to 300 mg thrice daily up to 7 d in continue 
treatment), short biological half-life (3 h) and reduced 
bioavailability (30–40 %). 
Thus, racecadotril is a candidate for the development of a 
gastroretentive drug delivery system. Due to mucoadhesion it may 
release drugs for a longer period and may increases bioavailability. 
Racecadotril is very slightly soluble in water and hence only 30-40 
% of the orally administered drug is absorbed. To enhance the 
extent of absorption, reduce dose, minimize the side effect of 
racecadotril, it needs to develop a gastroretentive drug delivery 
system i.e. Racecadotril in the form of mucoadhesive microsphere 
using combinations of natural polymers chitosan and xanthan gum 
for sustained release [8-10]. 
MATERIALS AND METHODS 
Racecadotril was obtained as a gift sample from Cadila Healthcare 
Limited (Ahmadabad), India. xanthan gum, dioctyl sodium 
sulphosuccinate, and chitosan were obtained from S. K. enterprises 
Pune, Maharashtra. Heavy and light liquid paraffin, glutaraldehyde 
was obtained from research lab Mumbai. Maharashtra. All other 
chemicals and reagents used in the study were analytical grade. 
Analytical method 
Racecadotril was analyzed for percent entrapment efficiency (EE %), 
percent cumulative drug release (% CDR), and percent 
mucoadhesion by UV spectrophotometer (Shimadzu-1800, Japan) in 
0.1N HCl by generating a standard curve for the range from 10 to 50 
µg/ml at 232 nm. 
Preparation of microspheres  
The mucoadhesive microsphere of racecadotril was prepared using 
the emulsification chemical cross-linking method. A 1 ml quantity of 
glacial acetic acid solution was dissolved in 100 ml of distilled water; 
it gives 1 %V/V solution of acetic acid. Chitosan was dissolved in 1% 
V/V aqueous acetic acid solution and Xanthan gum added in the 
water. The drug was added to a polymer solution. The resultant 
mixture was extruded through a syringe in liquid paraffin (heavy 
and light 1:1 ratio) containing dioctyl sodium sulphosuccinate and 
stirring was performed using magnetic stirrer after 10 min 
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glutaraldehyde (25 % aqueous solution) was added and stirring was 
continued for 3 h, microspheres thus obtained were filtered washed 
several times with petroleum ether to remove traces of oil. They 
were finally washed with water to remove an excess of 
glutaraldehyde and dried at room temperature [11-14]. 
The factorial formulations of racecadotril various microspheres 
formulations were mentioned in table 2.  
Experimental design 
A 22 factorial design was utilized in the present study. Several 
studies revealed that the concentration of glutaraldehyde and 
stirring speed plays a major role in % entrapment efficiency, % 
cumulative drug release and % mucoadhesion. The glutaraldehyde 
concentration and stirring speed were selected as independent 
variables. The % entrapment efficiency, % cumulative drug release, 
and % mucoadhesion selected as dependent variables. Minitab 17 
trial version was used for the generation and evaluation for the 
statistical experimental design. An ANOVA test was performed to 
evaluate the level of significance of the tested factors on the selected 
responses as well as the interaction between these factors. The 
application of regression analysis is important to check that our 
independent variable has a significant effect on our response or not. 
Surface response plots were also presented to graphically represent 
the effect of the independent variables on the % entrapment 
efficiency, % cumulative drug release and % mucoadhesion. 
  
Table 1: Variable levels in coded form 
Variable Low (-1) High (+1) 
X1= Stirring speed (rpm) 600 700 
X2= Concentration of glutaraldehyde 2 % 3 % 
 
Table 2: Factorial formulations of mucoadhesive microspheres of racecadotril 
Ingredients Formulation 
F1 F2 F3 F4 
Racecadotril (mg) 100 100 100 100 
Chitosan (mg) 200 200 200 200 
Xanthan gum (mg) 50 50 50 50 
Glutaraldehyde (ml) 2 3 2 3 
Stirring speed (rpm) 600 600 700 700 
1 % Acetic acid (ml) 25 25 25 25 
Distilled Water (ml) 5 5 5 5 
 
Particle size analysis 
The particle size of each formulation was determined by using 
Digital microscopy (Motic, Mumbai, India) method. Approximately 
50 microspheres were counted for particle size using a calibrated 
digital electron microscope under 10 x. 
Swelling index 
A pre-weighed amount (100 mg) of microspheres was placed in 
acidic buffer pH 1.2 and allowed to swell up to constant weight. The 
microspheres were removed and blotted with filter paper, and their 
changes in weight were measured [4]. The degree of swelling was 





Where Wo is the initial weight of microspheres and Wg is the weight 
after swelling. 
Entrapment efficiency 
Microspheres were filled in the 5 ml Centrifuge tube containing 
methanol. Perfectly sealed the cap of the tube. Placed the centrifuge 
on a firm level surface. The solution was filtered and the filtrate was 
diluted suitably and absorbance of the solution was recorded using a 
UV spectrophotometer at 232 nm and the value obtained used to 
determine the % EE of drug content [15]. 
Entrapment efficiency =
actual amount of drug
therotical amount of drug
× 100 
In vitro wash-off test (Mucoadhesive strength) 
The mucoadhesive properties of the microspheres were evaluated 
by the in vitro wash-off test. A 2x2 cm piece of Goat stomach mucosa 
was tied onto a glass slide (3×1 inch) using thread. Microspheres 
were spread (∽50) onto the wet, rinsed, tissue specimen, and the 
prepared slide was hung onto one of the groves of a USP tablet 
disintegrating test apparatus. The disintegrating test apparatus was 
operated such that the tissue specimen was given regular up and 
down movements in a beaker containing the acidic buffer pH 1.2. At 
the end of 1 h, the number of microspheres still adhering to the 
tissue was counted [17]. 
% mucoadhesion =
weight of adhering microsphere
weight of microsphere
× 100 
In vitro dissolution studies 
In vitro dissolution of the formulation was studied by taking the 
formulations equivalent to 100 mg of a drug in 0.1N HCL medium 
using the rotating paddle method at 37 °C±0.5 °C and at 100 rpm 
using 900 ml 0.1N HCL dissolution media. Microsphere placed in 
dissolution media. At a suitable time interval, the 5 ml sample was 
withdrawn from the dissolution apparatus and the sample was 
replaced with fresh 0.1N HCL. and analyzed at a particular 
wavelength of 232 nm by UV Spectrophotometer. Further, the exact 
mechanism of drug release from the microsphere was calculated by 
curve fitting release data. Different release kinetic models such as 
zero-order, first-order, Higuchi and the Korsmeyer-Peppas equation 
were checked. The date of release kinetics were calculated. 
FTIR spectroscopy 
The FT-IR spectrum of Racecadotril was recorded as potassium 
bromide (Kbr) powder at a resolution of 4000-40 cm-1 for its 
authentication and to study principle peaks using FT-IR 
spectrophotometer (FT-IR 8400S, Shimadzu).  
Morphology of microspheres 
The surface morphology and shape of the Racecadotril microspheres 
were determined by scanning electron microscopy (SEM). 
Differential scanning calorimetry analysis (DSC) 
The thermograph of the Racecadotril was studied on a Mettler 
Toledo India Pvt. Ltd (Model DSC Star1). An empty aluminum pan 
was used as a reference. DSC measurements were performed at a 
heating rate of 10 °C/min from 30 to 300 °C using an aluminum 
sealed pan. During the measurement, the sample was purged with 
nitrogen gas.  
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Release kinetic studies 
The rate and the mechanism of release of Racecadotril from the 
prepared mucoadhesive microspheres were analyzed by fitting the 
dissolution data into various kinetic models like zero order; first 
order, Korsmeyer Peppas, Higuchi’s model. 
Stability study 
The stability of pharmaceutical products may be defined as the 
capability of a particular formulation, to remain within its physical-
chemical microbiological therapeutic and toxicological specifications. 
The optimized formulation was filled into hard gelatin capsules (size 
0). These capsules were packed in screw-capped bottles were kept in 
the humidity chamber maintained at 40±0.5 °C and 75±5 % RH for 3 
mo. At the end of studies, Sample was analyzed for organoleptic 
properties, % Entrapment Efficiency and % Cumulative drug release, 
and % Mucoadhesion. 
RESULTS 
Characterization of drug and excipients 
FTIR spectroscopy 
The IR spectra did not show any significant difference from those 
obtained for their physical mixture. These results indicated that the 
above polymer can be used without any interaction for the 
preparation of the Mucoadhesive Microsphere of Racecadotril. 
Following fig. shows the IR spectra of racecadotril and physical 
mixture (1:1) of Chitosan, Xanthan gum, and guar gum. 
 
 
Fig. 1: FTIR spectra of (a) Racecadotril. (b) Racecadotril+Chitosan (c) Racecadotril+Xanthan gum (d) Racecadotril+Guar gum (e) 
Racecadotril+Chitosan+Xanthan 
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Differential scanning calorimetry analysis (DSC) 
DSC thermograph of a given sample of Racecadotril is shown in fig. 
2. The thermogram showed the Endothermic peak at 85.63 °C which 
is near to the actual melting point of the Racecadotril, from this it 
confirmed that the received gift sample of a drug is of Racecadotril. 
 
 
Fig. 2: DSC thermogram of racecadotril 
 
Table 3: Characterization of mucoadhesive microsphere of racecadotril in factorial batches 
Formulation *Particle size [µm] 
(Under 10x) 
*Swelling index *%Encapsulation efficiency *In vitro wash-off test (%Mucoadhesion) 
after 1 h 
F1 46±0.32 1.66 65.07±1.021 69.3±3.42 
F2 28±0.12 1.42 67.42±1.032 90.2±3.51 
F3 38±0.35 1.72 49.42±1.347 78.5±4.26 
F4  26±0.54 1.51 58.52±1.031 77.9±3.51 
 (*Represents mean n=3, ±SD: standard deviations) 
 
Characterization of mucoadhesive microsphere of Racecadotril 
in factorial batches 
All results were summarized in table 3. 
Analysis of factorial design  
The preliminary formulation screening data was utilized for defining 
design space in 22 full factorial designs shown in table 1 for an 
optimization study. The percent entrapment efficiency, Cumulative 
drug release, and % mucoadhesion were selected as response 
parameters, as they play a major role in providing the efficacy of the 
formulation. The ANOVA study of the model as shown in table 4 for 
percent entrapment efficiency as a response, indicated that the 
model is significant and all the independent variables, as well as 
interaction factors, are found to have a significant effect on the 
response (P ≤0.005). 
  
Table 4: Results of ANOVA for response parameter 
P Values of various response 
Source % EE % CDR % Mucoadhesion 
Model 0.001 0.001 0.001 
Linear 0.001 0.0001 0.001 
S-Stirring speed 0.001 0.001 0.001 
C-Conc of glutaraldehyde 0.001 0.001 0.0001 
 2-way interaction 0.001 0.001 0.000 
S*C 0.001 0.001 0.001 
 
The final regression model equation obtained was expressed in 
equation 1: 
% Entrapment Efficiency = 60.1725-2.91500 S+6.18500 C+1.63750 S*C 
Where it can be noticed that all the main factors have a positive 
influence on % EE. Where C is the concentration of glutaraldehyde 
and S is the stirring speed. The interaction effect also significant.  
Percentage entrapment efficiency was found to increase with an 
increased in glutaraldehyde Concentration and stirring speed. The 
formulation F2 showed the highest entrapment efficiency 
(67.42±1.032). The surface plot (fig. 3) showed a similar significant 
effect of stirring speed and glutaraldehyde concentration on % 
entrapment efficiency. 
% Cumulative drug release  
The in vitro release of all factorial batches were showed on the 
mucoadhesive microsphere (fig. 4). The drug release was 
studied for 6 h. The Model terms for response % cumulative 
drug release were found to be significant with P-
value<(p<0.005). As per ANOVA, all the factors found to be 
significant. The rate of drug release was found gradually 
increased by increasing the concentration of glutaraldehyde 
and decreased with an increase in stirring speed as shown in 
fig. 5 of the surface plot. The final regression model equation 
obtained was expressed in equation 2: 
% Cumulative drug release = 86.9900-4.2125 S+5.6650 C+0.4025 
S*C 
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Fig. 3: Surface plot and pare to chart of % entrapment efficiency 
 
 
Fig. 4: In vitro drug release profile of F1, F2, F3 and F4 in 0.1N HCl 
 
 
Fig. 5: Surface plot and pare to chart of % cumulative drug release 
 
Further, in vitro release data were subjected to the curve fitting 
analysis to know the complex mechanism behind the drug release. In 
the case of the majority of formulations, the R2 values were much 
higher for the Higuchi model and Korsmeyer-Peppas model n value 
near 0.5 (table 5) indicating the drug release from the formulation 
followed diffusion kinetics. 
 
Table 5: Data for study of release mechanism by curve fitting analysis 
Formulations Zero-order First-order Higuchi Korsmeyer's-Peppas Hixoncrowel model 
R2 R2 R2 R2 R2 
F1 0.9794 0.9271 0.9921 0.9813 0.9065 
F2 0.9644 0.9282 0.9932 0.9821 0.9036 
F3 0.9761 0.9295 0.9982 0.9885 0.9060 
F4 0.8979 0.9521 0.9355 0.9880 0.9473 
Where R2=Correlation for the Korsmeyers-Peppas, zero-order, Higuchi models, First-order and the Hixon-Crowell model 
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% Mucoadhesion 
Pareto chart (fig. 6) showed a comparison between relative 
magnitude and the statistical significance of both main and 
interaction effects. The above result conveyed that stirring speed 
plays an important role in the mucoadhesive property of the 
racecadotril microspheres. ANOVA table Values of Prob>P less than 
0.005 indicates the model term is significant. In this case, all the 
factors found to be significant. The study of in vitro mucoadhesion 
revealed that all the batches of prepared microsphere had good % 
mucoadhesion properties ranging from 69.3±3.42 to 90.2±3.51 %. It 
was investigating that an increased in glutaraldehyde concentration 
increased mucoadhesion strength. The formulation F2 showed the 
highest mucoadhesive property (90.2±3.51). These studies suggest 
that the spherical matrix of the microsphere can interact with many 
substrates on the surface of the stomach, and adhere to mucosa 
more strongly. The surface plot (fig. 6) showed the significant effect 
of an interactive factor on % mucoadhesion. It was observed that a 
decrease in stirring speed with a high level of glutaraldehyde 
concentration gave % Mucoadhesion value. 
The final regression model equation obtained was expressed in 
equation 3: 
% Mucoadhesion = 39.6900-0.4025 S+5.1600 C–1.5425 S*C 
Stability study 
The Short term accelerated stability data obtained for optimized 
formulation revealed that organoleptic characteristics, % 
entrapment efficiency and % cumulative drug release, 
mucoadhesion, and surface Morphology were within an acceptable 
limit. Thus the formulation can be said to be stable. 
 
 
Fig. 6: Surface plot and pareto chart of % mucoadhesion 
 
Table 6: Stability study of optimized mucoadhesive microsphere of Racecadotril formulation 
Initial Appearance Yellowish-white 
% Entrapment Efficiency 67.65 % 
% Cumulative drug release 96.43 % 
% Mucoadhesion 90 % 
After 3 mo Appearance Yellowish-white 
% Entrapment Efficiency 66.38 % 
% Cumulative drug release 95.36 % 
% Mucoadhesion 89 % 
 
 
Fig. 7: Surface morphology of optimized formulation 
 
SEM study 
Surface morphology (fig. 7) of optimized formulation was performed 
by using SEM. The study showed an almost spherical shape of the 
microsphere and having a porous nature. 
DISCUSSION 
DSC of pure drug sample showed a sharp endothermic peak at 85 °C 
which was near to its melting point range (72-74 °C). The nature of 
the peak showed the purity of the drug sample. The FTIR of pure 
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drug and mixture with xanthan showed all peak ranges are uniform. 
DSC and FTIR study showed that drug and excipients are compatible 
with each other.  
The mathematical models generated employing regression analysis 
and ANOVA were found to be valid, as the observed values for the 
response parameters 1)% Entrapment efficiency increases by 
increasing amount of glutaraldehyde and lowering the stirring 
speed, 2)% cumulative drug release increases by increasing 
concentration of glutaraldehyde and decreasing the stirring speed 
and also 3)% Mucoadhesion increases by increasing concentration 
and lowering stirring speed of the optimized formulations were in 
close agreement with the predicted values. This study also showed 
the response surface plot for all the responses. These studies 
showed that the experimental P values are less than 0.005 hence, 
showed the significance of the model for all the responses.  
The formulation F2 showed the highest bioadhesive strength (90.22 
% after 1 h), 96.43 % drug release at 6 h, and 67.65 % drug 
entrapment efficiency so selected as optimized formulation. Based 
on the preliminary study Combination of Chitosan and Xanthan 
shows good results hence selected for further study. Microspheres 
prepared by using guar gum-gt-acrylamide showed low entrapment 
efficiency(56.9±1.5) So, as per the above result using xanthan gum 
was better than guar gum-gt-acrylamide [18]. Optimized 
formulation F2 showed higher entrapment efficiency (67.42±1.032).  
The in vitro release data were subjected to the curve fitting analysis 
to know the complex mechanism behind the drug release, the drug 
release data to the Korsmeyers-Peppas model and the Higuchi 
model indicating that the drug release mechanisms from these 
microspheres were diffusion release. The stability study showed 
that there were no major changes made on microspheres. SEM study 
showed a porous spherical microsphere formulation. 
CONCLUSION 
The study revealed that the development of mucoadhesive 
microsphere.22 factorial designs was prepared and evaluated to 
study composition and processing factors. Regression analysis was 
carried out to obtain the regression coefficient effect as stirring 
speed and concentration of glutaraldehyde factor found to be 
significant for reponse1 % EE, 2 % cumulative drug release and 3 % 
mucoadhesion. The above result conveys that the amount of 
glutaraldehyde and stirring speed plays an important role in the 
formulation of the mucoadhesive microsphere. Based on the results 
of the dissolution profile, % Mucoadhesion and % Entrapment 
efficiency and good stability study. Factorial batch F2 was found to 
be optimized. 
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